Severe imported malaria in an intensive care unit: A case series

被引:5
作者
Al Farsi, Fatma [1 ]
Chandwani, Juhi [2 ]
Mandi, Asmaa S. [3 ]
Petersen, Eskild [3 ,4 ]
机构
[1] Oman Med Specialty Board, Med Microbiol Residency Program, Muscat 130, Oman
[2] Royal Hosp, Dept Intens Care, Al Ghubrah St, Muscat 111, Oman
[3] Royal Hosp, Dept Infect Dis, Al Ghubrah St, Muscat 111, Oman
[4] Univ Aarhus, Fac Hlth Sci, Inst Clin Med, Aarhus, Denmark
关键词
Severe malaria; Plasmodium falciparum; Vivax; ICU; FALCIPARUM-MALARIA; VIVAX;
D O I
10.1016/j.idcr.2019.e00544
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Complicated malaria is a medical emergency with a high mortality if untreated. Aim: To describe the clinical spectrum, treatment practices and outcome of severe malaria cases admitted to an intensive care unit. Method: Thirteen severe malaria cases admitted to the ICU over a 6 years period (2012 - October 2018) were included. The data was retrospectively extracted from the hospital patient data management system. Results: Nine patients had P. falciparum malaria, three had P. Vivax, and one had both. Only one had received malarial chemoprophylaxis. The median time of attending to medical health facility after symptoms started was 7 days (range: 2-21 days). All cases responded to antimalarial therapy and supportive management. Complications included shock 54%, kidney failure 38%, respiratory failure 69%, cerebral malaria 61%, hypoglycemia 23%, coagulation derangement 8%, and acidosis 23%. There were no fatal outcomes but one case had permanent brain damage and the rest recovered completely. Conclusion: The median treatment delay of seven days explains why these patients ended in intensive care with multiple symptoms of severe malaria and often multiorgan failure. Pretravel advice and use of malaria chemoprophylaxis when visiting high risk areas would probably have prevented infection and timely attendance to healthcare once symptomatic would have reduced the morbidity associated with infection, reduced length of stay in hospital and hence resources. (C) 2019 The Authors. Published by Elsevier Ltd.
引用
收藏
页数:5
相关论文
共 25 条
[1]   SIRS, qSOFA, and organ failure for assessing sepsis at the emergency department [J].
Andaluz, David ;
Ferrer, Ricard .
JOURNAL OF THORACIC DISEASE, 2017, 9 (06) :1459-1462
[2]  
[Anonymous], 2019, ANN HLTH REPORTS MIN
[3]  
[Anonymous], 2015, GUIDELINES TREATMENT
[4]   Malaria in selected non-Amazonian countries of Latin America [J].
Arevalo-Herrera, Myriam ;
Lucia Quinones, Martha ;
Guerra, Carlos ;
Cespedes, Nora ;
Giron, Sandra ;
Ahumada, Martha ;
Gabriel Pineros, Juan ;
Padilla, Norma ;
Terrientes, Zilka ;
Rosas, Angel ;
Cesar Padilla, Julio ;
Escalante, Ananias A. ;
Beier, John C. ;
Herrer, Socrates .
ACTA TROPICA, 2012, 121 (03) :303-314
[5]   The clinical spectrum of severe imported falciparum malaria in the intensive care unit -: Report of 188 cases in adults [J].
Bruneel, F ;
Hocqueloux, L ;
Alberti, C ;
Wolff, M ;
Chevret, S ;
Bédos, JP ;
Durand, R ;
Le Bras, J ;
Régnier, B ;
Vachon, F .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (05) :684-689
[6]   Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study [J].
Bruneel, Fabrice ;
Tubach, Florence ;
Mira, Jean-Paul ;
Houze, Sandrine ;
Gibot, Sebastien ;
Huisse, Marie-Genevieve ;
Megarbane, Bruno ;
Choquet, Christophe ;
Corne, Philippe ;
Peytel, Eric ;
Villers, Daniel ;
Camus, Christophe ;
Bouchaud, Olivier ;
Caumes, Eric ;
Girard, Pierre-Marie ;
Simon, Fabrice ;
Kalloumeh, Antoine ;
Roy, Carine ;
Durand, Remy ;
Bras, Jacques Le ;
Matheron, Sophie ;
Wolff, Michel .
INTENSIVE CARE MEDICINE, 2016, 42 (10) :1588-1596
[7]   Deaths caused by malaria in Switzerland 1988-2002 [J].
Christen, Daniel ;
Steffen, Robert ;
Schlagenhauf, Patricia .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 75 (06) :1188-1194
[8]  
Dondorp A, 2010, LANCET, V366, P717
[9]   Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial [J].
Dondorp, Arjen M. ;
Fanello, Caterina I. ;
Hendriksen, Ilse C. E. ;
Gomes, Ermelinda ;
Seni, Amir ;
Chhaganlal, Kajal D. ;
Bojang, Kalifa ;
Olaosebikan, Rasaq ;
Anunobi, Nkechinyere ;
Maitland, Kathryn ;
Kivaya, Esther ;
Agbenyega, Tsiri ;
Nguah, Samuel Blay ;
Evans, Jennifer ;
Gesase, Samwel ;
Kahabuka, Catherine ;
Mtove, George ;
Nadjm, Behzad ;
Deen, Jacqueline ;
Amumpaire, Juliet Mwanga ;
Nansumba, Margaret ;
Karema, Corine ;
Umulisa, Noella ;
Uwimana, Aline ;
Mokuolu, Olugbenga A. ;
Adedoyin, Olanrewaju T. ;
Johnson, Wahab B. R. ;
Tshefu, Antoinette K. ;
Onyamboko, Marie A. ;
Sakulthaew, Tharisara ;
Ngum, Wirichada Pan ;
Silamut, Kamolrat ;
Stepniewska, Kasia ;
Woodrow, Charles J. ;
Bethell, Delia ;
Wills, Bridget ;
Oneko, Martina ;
Peto, Tim E. ;
von Seidlein, Lorenz ;
Day, Nicholas P. J. ;
White, Nicholas J. .
LANCET, 2010, 376 (9753) :1647-1657
[10]   Artemisinin combination therapy for vivax malaria [J].
Douglas, Nicholas M. ;
Anstey, Nicholas M. ;
Angus, Brian J. ;
Nosten, Francois ;
Price, Ric N. .
LANCET INFECTIOUS DISEASES, 2010, 10 (06) :405-416